February 20, 2019
Alnylam Named a Fast Company World's Most Innovative Company for 2019
Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019.
Read More ›
December 11, 2018
John Maraganore Named to Bloomberg 50 List for 2018
Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018.
Read More ›
August 3, 2018
Barry Greene Named to PharmaVoice 100 "For Being an RNAi Champion"
Alnylam President Barry Greene has been named to the PharmaVoice 100 for 2018. Barry was selected "for being an RNAi champion."
Read More ›
January 18, 2018
Alnylam Co-Founds UK Biobank Exome Sequencing Consortium (UKB-ESC)
Alnylam and partners announced an agreement with the UK Biobank to form the UK Biobank Exome Sequencing Consortium (UKB-ESC), to sequence all 500,000 exomes...
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site